Clinical Trials Browser

Phase 2 × arsenous acid × Clear all

NCT01409161 2025-12-17

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT06678048 2025-06-06

Arsenous Acid for Refractory Triple-Negative Breast Cancer

Phase 2 Recruiting

Breast Neoplasms